Leveraging molecular targeted drugs and immune checkpoint inhibitors treat advanced thyroid carcinoma to achieve thyroid carcinoma redifferentiation. - Su JY; Huang T; Zhang JL; Lu JH; Wang ML; Yan J; Lin RB; Lin SY; Wang J (American journal of cancer research, 2024)